⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
ALEC News
Alector, Inc. Common Stock
Alector Reports Second Quarter 2026 Financial Results and Provides Business Update
globenewswire.com
ALEC
Alector Reports Second Quarter 2026 Financial Results and Provides Business Update
globenewswire.com
ALEC
Form 8-K
sec.gov
ALEC
Form 8-K
sec.gov
ALEC
Treg Cell-Based Therapies Clinical Trial Pipeline Appears Robust With 29+ Key Pharma Companies Actively Working in the Domain | DelveInsight
globenewswire.com
RAPT
SANG
INCY
ABBV
ARCT
AMGN
CHKP
PFE
LLY
SCLX
SNY
UCB
BIIB
NVS
VTRS
BMY
ABSI
ALEC
GSK
IONS
CLNN
ANNX
MED
GAM
VRTX
EXC
BLRX
Form 8-K
sec.gov
ALEC
Form 8-K
sec.gov
ALEC
Alector Reports First Quarter 2026 Financial Results and Provides Business Update
globenewswire.com
ALEC
Alector to Discontinue Phase 2 PROGRESS-AD Trial of Nivisnebart (AL101/GSK4527226) in Early Alzheimer’s Disease Following Interim Futility Analysis
globenewswire.com
ALEC
FASTPACE Expands C-PACE Partnership Network with Addition of SustainEnergyFinance, Utah's Green Bank
accessnewswire.com
ALEC